A CRO look­ing to build its man­u­fac­tur­ing side busi­ness has a new par­ent af­ter Keen­sight snaps up ma­jor­i­ty stake

Dutch CRO Symeres has looked to grow its man­u­fac­tur­ing side busi­ness, rec­og­niz­ing the ben­e­fit of syn­er­gy in con­tract re­search and pro­duc­tion. That dual mis­sion caught …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA